Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.59 USD | +0.29% | +4.89% | -5.36% |
Apr. 26 | North American Morning Briefing : Tech Still in -2- | DJ |
Apr. 25 | Deutsche Bank Upgrades Acadia Healthcare to Hold From Sell, Price Target is $70 | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company is in debt and has limited leeway for investment
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.36% | 6.8B | C+ | ||
-14.92% | 84.68B | B- | ||
+13.30% | 81.12B | C+ | ||
+11.62% | 29.4B | C+ | ||
-12.71% | 16.73B | B | ||
-3.06% | 16.36B | A- | ||
-2.63% | 14.92B | A- | ||
-31.75% | 11.77B | - | - | |
-1.42% | 11.72B | A- | ||
+27.44% | 11.71B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ACHC Stock
- Ratings Acadia Healthcare Company, Inc.